You just read:

Trovagene Announces Update to Phase 1b/2 AML Trial Data Presented at AACR - Additional Patients Achieve Complete Response at Two Highest Dose Levels of Onvansertib

News provided by

Trovagene, Inc.

Apr 05, 2019, 08:15 ET